Myriad Genetics Inc (MYGN)

Cash & Short-Term Investments

$115.20M

Quarterly · Period ending: · USD

MYGN logo

MYGN Cash & Short-Term Investments

Latest reported$115.20M
MYGN Quarterly Cash & Short-Term Investments ($28.60M → $115.20M)
High-resolution chart · PNG

MYGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
115,200,000
124,400,000
149,600,000
145,400,000
74,400,000
91,800,000
102,400,000
99,900,000
97,300,000
104,300,000
140,900,000
86,300,000
121,600,000
78,700,000
114,900,000
193,200,000
205,100,000
268,400,000
338,800,000
366,100,000
164,400,000
176,100,000
150,700,000
160,400,000
217,800,000
181,500,000
141,600,000
142,600,000
136,900,000
149,700,000
165,400,000
167,500,000
180,600,000
157,300,000
143,500,000
148,300,000
150,700,000
172,100,000
162,500,000
148,400,000
159,000,000
216,700,000
219,300,000
155,400,000
144,800,000
134,433,000
165,115,000
159,610,000
186,400,000
212,158,000
353,595,000
357,018,000
372,316,000
336,157,000
358,633,000
349,165,000
340,532,000
337,364,000
350,630,000
349,521,000
346,457,000
361,224,000
391,299,000
428,338,000
403,228,000
398,649,000
345,409,000
357,629,000
316,855,000
402,085,000
331,994,000
308,340,000
328,728,000
204,194,000
181,151,000
188,564,000
214,111,000
304,347,000
203,511,000
212,115,000
227,744,000
229,334,000
235,079,000
102,997,000
113,843,000
78,094,000
85,957,000
91,496,000
115,366,000
69,411,000
63,721,000
69,706,000
72,775,000
93,254,000
110,431,000
58,530,000
73,074,899
79,797,046
90,379,785
96,529,239
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.